Hopes for the Japanese approval of oral contraceptives have dimmed,after some members of a public health committee (PHC) involved in the review process said that they could discourage condom usage and lead to the spread of AIDS. The PHC does not have the power to approve or disapprove the pill, but was set up by the second of three committees required for approval, and only to determine the effects of such a move on the spread of sexually transmitted diseases. The second committee will not make any final decision until the PHC has come up with a report, the timetable for which is not clear.
Critics are now questioning the make-up of the PHC, reports Reuters, and note that none of its members are contraceptive specialists. They also feel that, after the scandal involving blood products tainted with HIV, the Health Ministry is overly-sensitive about AIDS. Worries about Japan's low birthrate and the desire for more conservative sexual ethics are also part of the backlash against approval of OCs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze